March 21, 2006 -- The US Food and Drug Administration (FDA) has approved first-time generic formulations of fluticasone propionate 50-µg nasal spray for the management of rhinitis symptoms in patients ...

Appco Pharma LLC (Appco) is voluntarily recalling all quantities and lots, within expiry, of Ranitidine Hydrochloride Capsules to the Consumer level. Ranitidine Hydrochloride Capsules are being ...

A new nationwide recall has been issued for a generic version of the heartburn and ulcer drug Zantac due to the potential presence of an impurity that could cause cancer. It's the fourth recall for ...

Details concerning the Ranitidine HCl combination medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, liquids, ...

March 13, 2007 — The US Food and Drug Administration (FDA) has approved first-time generic formulations for rabeprazole sodium 20-mg delayed-release tablets and ranitidine HCl 15-mg/mL oral ...

A voluntary recall of a generic version of Zantac has been issued because the drug has been found to contain a contaminant that could cause cancer. Sandoz Inc. is recalling 14 lots of prescription ...

* TILL DATE CO HAS NOT SOLD ANY RANITIDINE API FOR COMMERCIAL DISTRIBUTION IN THE U.S. * NO MATERIAL IMPACT ON CO'S CURRENT, FUTURE REVENUES OR MARGINS AS REVENUE FROM RANITIDINE IN PREVIOUS YEARS ...

Earlier this week, CVS, Rite Aid, and Walgreen’s suspended sales of Zantac (ranitidine) products. This follows the announcement last month by Sandoz, the generics division of Novartis, that it was ...

Pharmaceuticals firm Zydus Cadila today said it has received final approval from US health regulator to market generic Ranitidine Hcl (hydroclhoride) injection used in treating peptic ulcers. Advisory ...

Highlights: - Indian pharma impacted by regulatory headwinds for Ranitidine - Formulators/API manufacturers to test data within 30 days - Indian formulators can have sales impact of ~5 percent if ban ...

A new nationwide recall has been issued for a generic version of the heartburn and ulcer drug Zantac due to the potential presence of an impurity that could cause cancer. It's the fourth recall for ...